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child with the organic aciduria of glutaric aciduria type I1 in
The authors conclude that this disorder is not due to generalized whom transient hypersarcosinemia and sarcos,nu,.ia were also deficiency glutaryl-COA dehydrOgenase Or a defect in FAD detected. The results presented indicate that the disorder is not synthesis. The amino and organic acid abnormalities noted are due to generalized deficiency o f g l u t a r y l -~o~ dehydrogenase and most consistent with a defect in the flavoprotein which transfers not to a block in FAD synthesis. *lthough the specific the FAD sarcOsine and acy'-COA dehydrOgenases cause of the disease remains obscure, the results are most consistent into the respiratory chain, although a defect in intercompartmental with a defect of the electron transfer flavoprotein which transfers transfer of C4-5 acyl CoA esters across cell membranes is not electrons from the FAD of sarcosine and a c y l -~o~ dehydrogenexcluded.
asesinto the respiratory chain. The variability of the organic aciduria, which possibly reflects changes in protein and fat intake, suggests that a previous name for this disorder, ie., glutaric aciduria type 11, is inappropriate and CASE REPORT should be replaced, perhaps by "multiple acyl-CoA dehydrogenase deficiency."
The patient, a full term male, weighed 3.6 kg on delivery by Csection. His only sibling, a girl, had been born 1 yr earlier after a difficult labor, had appeared normal at birth (Apgar at 5 min = Speculation lo), but became lethargic in hospital and died suddenly at 4 days What appears to be simultaneous deficiency of several acyl-CoA of age. Autopsy showed cerebral edema and diffuse fatty infiltradehydrogenases may be caused by a number of different primary tion of hepatic parenchymal cells, and the parents were told that gene defects; the presence of hypersarcosinemia and/or sarcosi-the child had died Of Reye's syndrome. nuria may delineate a subtype due to deficiency of an electron The appeared at lo hr Of age* but 24 hr later was carrier flavoprotein. Further, the presence of organic aciduria may feeding poorly and had become lethargic* hypotonic and acidemic define a form of hypersarcosinemia more likely to be associated (serum bicarbonate =: 10 mEq/liter). He was transferred to Loma with phenotypic abnormalities than isolated deficiency of the Linda Medical Center where admission examination showed sarcosine dehydrogenase apoenzyme.
tachypnea with grunting respirations, hypotonia, and slight hepatomegaly. A foul odor was noted on the 3rd day of life, but was transient and not investigated further. Early lab values included; Glutaric aciduria type I1 is the name given to a disorder, to date hemoglobin 11.8 g/dl, white blood cell count 15,300/mm%ith described in only one male child, in which severe metabolic 79% segmental polymorphonuclear leukocytes and 21% lymphoacidemia, hypoglycemia, and death in early infancy was associated cytes, platelets 273,000/mm3, glucose 9 mg/dl, bilirubin 5.5 mg/dl I2 I ACYL-COA DEHYDROGENASE DEFICIENCY 13 I (direct 0.2), and calcium 1.68 mM. Chest X-ray and cerebrospinal fluid were normal. The initial impression was sepsis and, after appropriate cultures had been drawn, glucose and antibiotics (ampicillin and kanamycin) were administered iv. All cultures were negative. ~ethargy, poor feeding with regurgitation, and failure to gain weight even on gavage feedings persisted during the next 2 wk; blood ammonia measured during this period was 56 pg/dl. A trial of intravenous amino acids (Freamine 11. 4 g amino acids/kg/day) was begun on the 17th day of life; within 12 hr compensated metabolic acidemia (serum bicarbonate = 15 mEq/liter) and an odor of sweaty feet had become obvious and urine organic acid chromatography was ordered to confirm a diagnosis of isovaleric acidemia. The chromatogram shown in Figure I (top) was obtained, and on this basis, the probable diagnosis was changed to glutaric aciduria type 11.
Feeding with a low-protein diet did not alter the clinical course. Poor weight gain and chronic regurgitation persisted and he died at the age of 5 months, with autopsy showing severe fatty changes in the liver, kidneys, and skeletal and cardiac muscle. No changes were noted in the basal ganglia (13) . (The amount of protein given the child after diagnosis is in question; the diet prescribed contained 1.2-1.4 g/kg/day but the amount given may have been half that. Several of the clinical and laboratory findings during the last admission (edema, total protein = 4.0 g/dl, hematocrit = 24.8) were consistent with protein malnutrition, and the contribution this may have made to the anatomic and biochemical findings in tissues cannot be evaluated.)
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MATERIALS AND METHODS
Autopsy was performed 3 hr after death; samples of liver and kidney were frozen immediately and maintained at -20" until assayed for enzyme activity. Urine and serum samples were maintained at -20° before analysis for amino and organic acids.
Urine and serum amino acids were measured on a Beckman model 121M amino acid analyzer using lithium citrate buffers. Urine organic acids were examined as described previously (10) and peaks were identified by combined gas chromatography-mass spectroscopy using an AEI MS-12 medium resolution instrument. Organic acids were quantitated by gas chromatography using appropriate internal and external standards to correct for extraction efficiency and size of injection.
Fibroblast culture was established from pinch-skin biopsy and the cells grown in minimum essential medium with Earle's salts containing 15% fetal bovine serum, non-essential amino acids, and antibiotics. Oxidation of glutaryl-CoA fibroblast sonicates was determined as previously described (1 1); assays were performed with and without added FAD.
Oxidation of glutaryl-CoA in frozen tissues was measured by a modification of a method described for use on isolated mitochondria (2). Tissue was homogenized and then sonicated in 9 volumes 0.02 M potassium phosphate pH 7.5 with 0.001 M cysteine, and 0. l ml of the sonicate was incubated for 10 min at 37" in a 1 ml mixture containing 60 pmole potassium phosphate, pH 7.5, 0.1 pmole cysteine, 0.1 pmole FAD, 1 pmole methylene blue, and (usually) 0.1 pmole (1,5-'4C)glutaryl-CoA (specific activity, 1.6 mCi/mmole) (12) . Reactions were stopped with 0.5 ml 25% TCA and COP was trapped in 10% KOH and counted in a Beckman LS-233 liquid scintillation counter. Assays were also performed on acetone-extracts of liver and on sonicates which had been dialyzed for 16 hr at 4' against homogenizing buffer. Glutamate dehydrogenase activity in liver was measured by a standard method (25) .
To examine incorporation of riboflavin into FMN and FAD by kidney, tissue was homogenized in 4 volumes 0.15 M potassium phosphate, pH 7.5, and 0.2 ml of the homogenate was incubated in the dark for 1 hr at 45" in a 1 ml mixture containing 75 pmole potassium phosphate pH 7.5, 1 pmole MgC12, 0.1 p o l e ZnSO., I pmole ATP, and 0.5 pCi D-(2-14C)riboflavin (specific activity 31 mCi/mmole; Amersham/Searle). Reactions were terminated by adding 2.4 ml methanol which contained riboflavin, FMN and FAD (1.2 mg each). After mixing and centrifugation (60,000 x g at 4" for 30 min), 250 pl of the supernatant was applied to a 1 X 14 cm column of DEAE-Sephadex A-25 resin and the flavins eluted with 1% ammonium sulfate. Pooled fractions of riboflavin, FMN, and FAD were lyophillized to dryness and counted (6) .
RESULTS
AMINO ACIDS
Urine amino acids were normal for age on all occasions on which they were measured except at 19 days when, after 2 days of parenteral hyperalirnentaion, a generalized aminoaciduria especially marked in glycine (1.957 g/g creatinine), methionine (I ,602 g/g creatinine), and lysine (0.829 g/g creatinine), and a peak with the elution and 570/440 mp absorbance ratio characteristics of sarcosine (1.148 g/g creatinine) were observed. Serum amino acids were determined on four occasions ( Table 1) . They were not measured on day 19, but 4 days later, when the child received 2 g amino acids/kg iv, serum sarcosine was 0.140 pmole/ml (normal = not detected). On the other occasions, noted intake was entirely oral but severely restricted in protein, and hypersarcosinemia was not detected. Table 2 shows the longitudinal excretion of the more prominent organic acids found in the urine. The chromatogram at 19 days, when iv amino acids approximated 4 g/kg, is shown in Figure I (top); the large abnormal peaks of isovalerylglycine and P-hydroxyisovaleric, glutaric and a-hydroxyglutaric acids are apparent as are smaller, albeit also abnormal, peaks due to a-hydroxyisobutyric acid, methylsuccinic acid, isobutyrylglycine, and a-methylbutyrylglycine. Ethylmalonic acid was not detected at this time but, together with methylsuccinic and a-hydroxyglutaric acids, was prominent in other samples, e.g., Figure 1 (bottom), when daily protein intake was less than 2 g/kg. Small amounts of lactic and adipic acids were observed only intermittently, and suberic and sebacic acids were never detected. Other organic acids not detected included glutaconic and P-hydroxyglutaric, which are usually seen in isolated deficiency of glutaryl-CoA dehydrogenase (29) . and 11-hexanoylglycine, which has been observed in ethylmalonic aciduria (33) and in Jamaican vomiting sickness (32). Activity of glutaryl-CoA dehydrogenase in cultured fibroblasts of the patient was 5.89 nmol CO,/hr mg protein in the presence of 0.1 x 10-3M FAD (normal = 1.90-6.18; n=20) and in its absence was 1.16, i.e., 20% of FAD-supplemented activity. In two control lines assayed simultaneously, activity without FAD was 30 and 35% of that observed when FAD was present. Further investigations on these cells were not possible as the cells did not surviv; storage in liquid nitrogen.
ORGANIC ACIDS
- Table 3 shows activities of glutaryl-CoA dehydrogenase and glutamate dehydrogenase, a mitochondria1 marker, in frozen tissues of the patient and three control subjects. Glutaryl-CoA dehydrogenase activity was not detected in liver and was extremely low in kidney; control values show that this deficiency cannot be accounted for by storage for 5 months at -20". Activity was not restored by acetone extraction or dialysis; dialysis reduced the activity in normal liver by 50%. When patient and control sonicates were mixed, activity was within 3% of predicted. Activity was not restored by 10-fold increases in either glutaryl-CoA or FAD. Table 4 shows the incorportion of radioactivity from D-(2-14C)riboflavin into FMN and FAD by homogenates of kidney from the patient and three control subjects; all tissues had been at -20" for comparable periods. There is no obvious difference in incorporation of radiolabel between test and control tissues.
DISCUSSION
The similarity of the clinical course (early onset of metabolic acidemia and severe hypoglycemia), autopsy findings, and the organic acid excretion pattern to that observed in the only reported patient with glutaric aciduria type I1 suggests that the child described in this communication had the same or a closely related disorder. A similar disease, albeit with an earlier fatal outcome, in a previous female sibling of the present patient suggests that the disorder is inherited and, if so, that it is transmitted as an autosomal recessive trait.
The abnormal serum and urine amino acids noted in the initial case report were not observed. However, the abnormalities noted in that child are not specific, having been observed in Reye's syndrome (16, 19, 27) , and their relation to the child's then moribund state cannot be evaluated. In our patient, aside from transient elevations of sarcosine in serum and urine, serum amino acids were consistent with intravenous administration of amino G, glutaric; H, isobutyrylglycine (monoTMS); I, adipic; J, a-hydroxyglutaric; K, isovalerylglycine (monoTMS); L, p-hydroxyphenylacetic. Small amounts of a-methylbutyrylglycine were detected by MS in the peak of isovalerylglycine on day 19, and large amounts of isobutyrylglycine (diTMS) were present in the descending arm of the glutaric acid peak. acids (9) on one occasion (day 23) and with severe restriction of protein intake (28) on others (days 42, 56, 63) and urine amino acids were normal. Sarcosinemia of the amount noted, i.e., 0.140 pmole/ml, has 15 been observed in hypersarcosinemia and after oral loads of sar-duced from a-methylbutyric via ethylhydracrylic (22), its absence cosine (100 mg/kg) to normal subjects (7, 26) . Sarcosine is not a from urine only during a period of no lipid intake, i.e., parenteral component of the amino acid solution infused into this child, nor hyperalimentation, suggests that derivation from butyryl-CoA is is sarcosinemia and/or sarcosinuria a usual finding during par-more likely. enteral hyperalimentation (9, 14) . Hypersarcosinemia is apparThe blocks in acyl-CoA metabolism, whatever their cause, are ently due to inherited deficiency of sarcosine dehydrogenase (sar-appreciable. For instance, glutaric acid excretion at diagnosis (26 cosine: O2 oxidoreductase; E.C. 1.5.3. I), a mitochondrial enzyme mg/mg creatinine) was 50% greater than that noted in a comresponsible for oxidative demethylation of sarcosine to glycine, pletely glutaryl-CoA dehydrogenase-deficient child (12) after a and the phenotype is quite variable. Some patients have been lysine load, and the amounts of P-hydroxyisovaleric acid and described with a course similar to that described herein, whereas isovalerylglycine were comparable to what is observed in isolated other individuals have been normal (8) .
deficiency of isovaleryl-CoA dehydrogenase (14, 30,3 1) . Further, Organic acids excreted in severe ketosis, i.e., lactic, P-hydroxy-urine ethylmalonic acid (0.06-1.9 mg/mg creatinine) is comparabutyric, adipic, suberic, and sebacic (23) , were prominent in the ble in amount to that observed in human hypoglycin ingestion initial patient reported but not in the present case; other than this, (32, 34) and in a disorder attributed to isolated deficiency of however, the organic aciduria is much the same (Fig. 2) . The butyryl-CoA dehydrogenase (33) . glycine conjugates of isovaleric, isobutyric, and a-methylbutyric
The acyl-CoA esters whose metabolism is apparently blocked acids suggest blocks in the metabolism of isovaleryl-CoA (leucine), are all synthesized in mitochondria; isovaleryl-CoA, isobutyrylisobutyryl-CoA (valine), and a-methylbutyryl-CoA (isoleucine); CoA, a-methylbutyryl-CoA, and glutaryl-CoA by oxidative dep-hydroxyisovaleric and a-hydroxyisobutyric acids might be prod-carboxylation of a-ketoacids and butyryl-CoA by thiolase-cataucts of (w-1)-oxidation of isovaleric and isobutyric, and methyl-lyzed cleavage of P-ketohexanoyl-CoA. Oxidation of these esters succinic might derive from w-oxidation of either isovaleric or a-also occurs in mitochondria, but possibly in a different compartmethylbutyric. Gultaric aciduria indicates a block in glutaryl-CoA ment. For instance, branched-chain keto-acid dehydrogenases are oxidation (lysine, tryptophan, and hydroxylysine), and ethylma-situated on the outer surface of the inner mitochondrial membrane lonic aciduria suggests that fatty acid oxidation is blocked at (18) and oxidation of the acyl-CoA products occurs in the matrix, butyryl-CoA (34) . Although ethylmalonic acid can also be pro-on the opposite side of the membrane. Appreciable quantities of the carnitine esters of isovaleric, isobutyric, a-methylbutyric, and butyric acids have been found in mammalian heart, liver, and Table 4 . Incorporation of D -(2-14c) riboflavin into FMN and FAD muscle, in accord with the possibility that a membrane is traversed by kidney homogenates between formation of the CoA esters and their oxidation (3, 5).
FMN4.p.m. FAD4.p.m.
The first oxidative step for all these acyl-CoA esters is dehydrogenation, and each may have its own specific FAD-dependent 
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GOODMA latter (I), their oxidation may require the presence of yet other enzyme(s). Dehydrogenation of the acyl-CoA esters is accompanied by reduction of apoenzyme-bound FAD to FAD.2H, from which electrons pass into the electron transport chain. An electron transfer flavoprotein is intermediate between the FAD of butyrylCoA dehydrogenase and coenzyme Q of the respiratory chain, and the same electron transfer flavoprotein transfers electrons from the FAD of sarcosine dehydrogenase (17) . The site of entry of electrons from the FAD of other acyl-CoA dehydrogenases is not known, but is assumed to be the same.
Possible causes of the many enzyme deficiencies apparently present in this condition thus include (1) mutation of a protein subunit common to acyl-CoA and sarcosine dehydrogenases, (2) defective synthesis of FAD, the common coenzyme, (3) enzyme inhibition, (4) a defect in intercompartmental transfer of acyl-CoA esters, and (5) deficient recycling of apoenzyme-bound FAD.2H.
There is no evidence that acyl-CoA (and sarcosine) dehydrogenase share a common subunit, but the subunit structure of most of these enzymes has not been elucidated and the existence of such a protein can, thus, not be excluded. However, activity of glutaryl-CoA dehydrogenase in fibroblasts of the patient was normal indicating that, unless the subunit is present in some tissues and not in others, mutation of a common protein is not responsible for the disorder.
A generalized defect in FAD synthesis is apparently excluded as the cause of this disorder, since normal incorporation of D-(2-'4C)riboflavin into FMN and FAD by frozen kidney and normal fibroblast activity of glutaryl-CoA dehydrogenase in the absence of added FAD indicates that FAD is synthesized normally in these tissues. The failure of FAD to restore glutaryl-CoA dehydrogenase activity to enzyme-deficient tissues (liver and kidney) supports this contention. (The authors have also examined fibroblasts from the original patient with glutaric aciduria type 11 (14, 36) . Glutaryl-CoA dehydrogenase activity is normal with and without added FAD, morphology and enzyme activity are no more sensitive to riboflavin-deficient medium than other cell lines, and the cells incorporate D-(2-14C)riboflavin in the inedium into FMN and FAD normally. These data suggest that the defect in that patient was likewise not one of FAD synthesis.)
It is also unlikely that the glutaryl-CoA dehydrogenase deficiency noted in liver (and kidney) is due to enzyme inhibition, unless the inhibitor is extremely tightly bound or inhibition is accompanied by enzyme destabilization. Enzyme activity was not restored to liver by acetone extraction, dialysis, or by increasing the substrate concentration, nor did mixing experiments indicate the presence of an inhibitor. Further, the identity of such an inhibitor is not readily apparent. No unusual drugs were given after or immediately before birth, and amino and organic acid analysis provide no obvious suspects. Methylsuccinyl-CoA and ethylmalonyl-CoA are poor inhibitors of glutaryl-CoA dehydrogenase; they inhibit the enzyme very little in the presence of FAD and, in its absence, by only 3040% even when their concentrations are 3-4 times the 0.1 X 10-3M concentration of glutaryl-CoA (14) .
The possibility that the organic aciduria is due to failure of certain acyl-CoA esters to traverse membrane barriers, such as might be caused by a mutation of carnitine acyltransferase on the inner mitochondrial membrane, cannot be excluded. Indeed, nonparallel purification of carnitine transferases for acetyl-CoA and isobutyryl-CoA in pigeon breast has suggested the existence of transferases specific for C4-5 acyl-CoA esters (4). This possibility is consistent with normal glutaryl-CoA dehydrogenase activity in disrupted fibroblasts, but does not easily accommodate either the enzyme deficiency noted in frozen tissues or the hypersarcosinemia and sarcosinuria.
The organic aciduria is also consistent with a defect in recycling apoenzyme-bound FAD.2H, i.e., with a defect in the transfer of electrons into and through the electron transport chain. In view of the central location of this process, survival might not be possible with such a defect unless it were incomplete or involved a component not in the mainstream of electron transport. A defect in the flavoprotein which transfers electrons from the FAD of sar-.N ET AL.
cosine and acyl-CoA dehydrogenases to coenzyme Q is an obvious possibility, particularly as it accounts for simultaneous accumulation of organic acids and sarcosine. Normal in vitro activity of glutaryl-CoA dehydrogenase in fibroblasts is consistent with this defect because FAD is recycled by methylene blue in the assay used. Again, the apparent deficiency of glutaryl-CoA dehydrogenase in frozen tissue is not easily explained unless it is due to enzyme destabilization, perhaps by reduced FAD.
Insofar as none of the previously mentioned theories can satisfactorily account for glutaryl-CoA dehydrogenase deficiency in frozen liver and kidney, none is wholely acceptable. Further, none of them explains the profound a-hydroxyglutaric aciduria which has been present in both patients and which, in our experience, is distinctly unusual. A possible source is reduction of a-ketoglutarate behind secondary inhibition of a-ketoglutarate dehydrogenase but, if so, the identity of the inhibitor is not obvious; long-chain acyl-CoA esters inhibit this enzyme but short-chain acyl-CoA esters do not (21) . On balance, however, the authors believe that the biochemical findings are most consistent with a defect in the flavoprotein which transfers electrons from the FAD of sarcosine and acyl-CoA dehydrogenases into the respiratory chain, although a defect in the intercompartmental transfer of C4-5 acyl-CoA esters is not excluded. Whatever the defect, the excretion of glutaric and other organic acids in this disorder is extremely variable, perhaps depending mainly on the amounts of dietary protein and fat. It appears, therefore, that glutaric aciduria type I1 is not an appropriate name for this condition and it is suggested that, pending the elucidation of the primary defect, it be replaced by multiple acyl-CoA dehydrogenase deficiency.
